An important piece of evidence has shown that molecules acting on cannabinoid receptors
influence gastrointestinal motility and induce beneficial effects on gastrointestinal …

Simple Summary The endocannabinoid system (ECS) has opened the door to novel
therapeutical approaches targeting cancer, pain, anxiety, stress, and inflammatory diseases …

A growing body of literature indicates that activation of cannabinoid receptors may exert
beneficial effects on gastrointestinal inflammation and visceral hypersensitivity. The present …

Background Cannabinoid receptors are involved in visceral pain perception and control of
intestinal motility in vivo. The underlying mechanisms are not well characterized. We aimed …

The endocannabinoid system (ECS) is composed of cannabinoid receptors, their
endogenous ligands, and the enzymes involved in endocannabinoid turnover. Modulating …

The gastrointestinal tract plays a crucial role in nutrient absorption, secretion, and motility,
ensuring proper digestion and overall homeostasis. Regulation of this complex system …

Background Cannabinoid (CB) receptors are involved in the regulation of gastrointestinal
(GI) motility under physiological and pathophysiological conditions. We aimed to …

The identification of endocannabinoids and cannabinoid CB1 receptors in key areas of the
intestinal wall, such as cholinergic neurons, supports a role for cannabinoids in the control of …

Cannabinoid signalling is an important mechanism of synaptic modulation in the nervous
system. Endogenous cannabinoids (anandamide and 2‐arachidonyl‐glycerol) are …

The plant Cannabis has been known for centuries to be beneficial in a variety of
gastrointestinal diseases, including emesis, diarrhea, inflammatory bowel disease and …